首页> 外文会议>International Workshop on Cardiac Arrhythmias >What Is the Best Practical Scheme for Initiating Oral Anticoagulant Treatment in Outpatients with Atrial Fibrillation?
【24h】

What Is the Best Practical Scheme for Initiating Oral Anticoagulant Treatment in Outpatients with Atrial Fibrillation?

机译:在心房颤动的门诊患者中启动口服抗凝血治疗的最佳实用方案是什么?

获取原文

摘要

Patients with atrial fibrillation (AF) have an approximately four-fold increased risk of stroke and systemic embolism [1]. Generally thrombus forms in the left atrial appendage because of the relative inactivity of the atria during AF [2]. The risk of stroke exists in all patients with AF, but the incidence of stroke is related to coexistent cardiovascular disease, hypertension, diabetes, or previous stroke [3,4]. Advancing age is associated with increased stroke risk, probably due to the effect of left atrium enlargement and left ventricular diastolic dysfunction, frequently observed in elderly patients [5, 6]. Nearly half of AF-associated strokes occur in patients older than 75 years.Antithrombotic strategy for prevention of stroke and systemic embolism is based on the results of large randomized trials which showed that adjusted-dose oral anticoagulation with warfarin is highly efficacious in preventing stroke, with a risk reduction of 68(percent) versus placebo [7]. This reduction is similar for both primary and secondary prevention.
机译:心房颤动的患者(AF)具有大约四倍的卒中风险和全身性栓塞的风险[1]。通常,由于ATRIA期间AF的相对不活跃,通常在左心房附属中形成。所有AF的患者都存在中风的风险,但行程的发生率与共存心血管疾病,高血压,糖尿病或先前中风有关[3,4]。推进年龄与增加的卒中风险有关,可能是由于左心房增大和左心室舒张功能障碍的影响,在老年患者中经常观察到[5,6]。近一半的AF相关中风发生在75岁的患者中。预防卒中和全身栓塞的恒菌策略是基于大型随机试验的结果,该试验表明,随着Warfarin的调整剂量口服抗凝凝血在预防中风方面具有高度有效,风险降低68(百分比)与安慰剂[7]。这种减少类似于初级和二级预防。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号